Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Approaches for breaking the barriers of drug permeation through transdermal drug delivery
Certain people are at a higher risk of sulfa allergy than others
Mounjaro (Tirzepatide) Mounjaro is a newer option with dual-action benefits, targeting both GLP-1 and GIP receptors
During the transition: Monitor blood glucose more frequently for the first 4 to 6 weeks Expect potential hypoglycemia risk if also taking insulin or sulfonylureas Your provider may need to adjust other diabetes medications A1C improvements may be more pronounced with tirzepatide The SURPASS clinical trials demonstrated that tirzepatide 15 mg reduced A1C by up to 2.58%, compared to semaglutide 1 mg which reduced A1C by 1.86%
US$ 28.72
US$ 26.27
US$ 20.49
US$ 28.95
US$ 27.33
